The program booklet is available for download (PDF 12.7 MB) and online viewing. The conference compendium will be available soon.
GEORGE L. KING, M.D. is the Senior Vice President, Chief Scientific Officer, and Head of the Section on Vascular Cell Biology at Joslin Diabetes Center, as well as a Professor of Medicine and Ophthalmology at Harvard Medical School.
Dr. King received his medical degree from Duke University School of Medicine. Dr. King’s work focuses on finding the causes of diabetic complications, exploring insulin actions on blood vessels, discovering factors and new treatments for diabetic complications, and understanding the reasons for the high rate of diabetes in Asian Americans. Dr. King has published over 270 articles and reviews.
WILLIAM (BILL) CHIN, M.D. Dr. Chin is Chief Medical Officer (CMO) of Frequency Therapeutics and Bertarelli Professor of Translational Medical Science and Professor of Medicine Emeritus at Harvard Medical School (HMS).
He is formerly Executive Vice President for Science and Regulatory Advocacy and CMO at Pharmaceutical Research and Manufacturers of America (PhRMA) where he led PhRMA’s continuing efforts in science and regulatory advocacy in the drug discovery and development ecosystem. Prior to PhRMA, he was the Executive Dean for Research at HMS. Before that, he was at Eli Lilly and Company last as Senior Vice President for Discovery Research and Clinical Investigation.
Dr. Chin is a Harvard-trained endocrinologist and longstanding faculty member. His career is highlighted by leadership in molecular endocrinology and translational science and medicine during his 25 years on the Harvard Medical School faculty. During this time, Bill was Chief of the Genetics Division in the Department of Medicine at Brigham and Women’s Hospital, a Howard Hughes Medical Institute Investigator and Professor of Medicine at HMS. He has been honored with numerous awards for research, mentorship and leadership. Bill received his A.B. in Chemistry from Columbia University and his M.D. from Harvard Medical School.
IGNATIUS BAU, J.D. is a health care policy consultant for the National Council of Asian Pacific Islander Physicians, and the editor of the reports from the Asian American, Native Hawaiian, and Pacific Islander Diabetes Coalition’s summits in 2011, 2014 and 2016.
He also has worked as a consultant for the American Diabetes Association, Asian and Pacific Islander American Health Forum (APIAHF), and Association of Asian Pacific Community Health Organizations. Bau has worked as interim executive director at the California Pan-Ethnic Health Network, program director at The California Endowment, deputy director for policy and programs at APIAHF, and immigration attorney at the Lawyer’s Committee for Civil Rights. At APIAHF, he led community efforts that resulted in Executive Order 13125, establishing the first White House Initiative on Asian Americans and Pacific Islanders. He was the principal author of the 2001 and 2014 reports from the President’s Advisory Commission on Asian Americans and Pacific Islanders. Bau has served on expert advisory groups for the federal Office of Minority Health, National Institutes of Health, Centers for Disease Control and Prevention, Institute of Medicine, National Quality Forum, Joint Commission, and Institute for Healthcare Improvement.
HO LUONG TRAN, M.D., M.P.H. is the President & CEO of the National Council of Asian Pacific Islander Physicians (NCAPIP) and is one of the founders of the AANHPI Diabetes Coalition.
Dr. Tran came from a compelling history as a Vietnamese refugee and built an inspiring twenty year government and public health service career. She is a recognized visionary leader and compassionate advocate for the advancement of well-being of ethnic communities. In her decades of work on health disparities, she has made it her goal to make sure AANHPI populations are included in research, policy, and the broader conversation on health equity and what constitutes “optimal health for all.”
Dr. Tran chaired the State of Illinois Governor’s Advisory Council on Asian Affairs and the City of Chicago Mayor’s Council on Immigrant and Refugee Affairs. She has been appointed to many commissions, including the HHS Secretary’s National Minority Health Advisory Council. Dr. Tran received a doctor of medicine degree from Saigon Medical School, completed a Pediatrics residency at St. Luke Presbyterian Medical Center in Chicago, and received a master’s degree in Public Health at the University of Illinois.
WILFRED Y. FUJIMOTO, M.D. is Professor Emeritus of Internal Medicine (Endocrinology and Metabolism), University of Washington, and Visiting Professor, Jichi Medical University-Saitama Medical Center (Japan).
He attended Johns Hopkins University (BA 1962, MD 1965), followed by postgraduate education at Columbia Presbyterian Medical Center, National Institutes of Health, and University of Washington. He has been a Visiting Researcher at the University of Tokyo (1979- 1980). He led the “Japanese American Community Diabetes Study” that described the etiology and pathophysiology of diabetes within this population. Among his many awards are the Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (1999), the Robert H. Williams-Rachmiel Levine Award from the Western Metabolism Club (2000) for mentoring junior faculty and fellows, and the Asian Association for the Study of Diabetes Yutaka Seino Distinguished Leadership Award (2015) recognizing his lifetime achievements and exceptional contributions to diabetology in Asia.
WILLIAM C. HSU, M.D. is Vice President at Joslin Diabetes Center leading the International Programs to establish culturally relevant diabetes care programs in more than 10 countries.
As Founder and Medical Director of Joslin’s Asian Clinic, Dr. Hsu spearheaded Joslin’s efforts to provide culturally tailored care for Asian Americans. In that role, Dr. Hsu published key research on diabetes care, and conducted numerous community and national projects to address health disparities in this population. As a subject expert, he has co-authored national Standards of Care and a Position Statement for the American Diabetes Association to redefine weight cut point for Asian Americans at risk for developing diabetes. More recently, he has focused his research on digital health to support diabetes management.
Dr. Hsu graduated from Cornell University and received his medical degree from Mount Sinai School of Medicine. He completed his residency training in Internal Medicine at Yale School of Medicine and fellowship training in Endocrinology at Harvard Medical School.
EDWARD CHOW, M.D. is an internist in practice in San Francisco for over forty-five years. He was the Executive Director of the Chinese Community Health Care Association, and Chief Medical Officer of the Chinese Community Health Plan.
He is Chair of the American Diabetes Association Action Council (APADAC), co-chair of the Asian American Native Hawai’ian and Pacific Islander Diabetes Coalition; member-at-large of the Federation of Chinese American and Chinese Canadian Medical Societies Board of Directors; and founding member of the National Council of Asian Pacific Islander Physicians. He is Principal Co-Investigator of the Asian American Network for Cancer Awareness, Research and Training (AANCART), President of the San Francisco Health Commission, and Chair of the Zuckerberg San Francisco General Hospital Joint Conference Committee. He is currently President and CEO of Jade Health Care Medical Group, affiliated with the Chinese Hospital Health System.
DAVID HAWKS is NCAPIP’s deputy director, handling program management, government affairs, fundraising, communications, operations, and strategic development.
He is the coordinator for the AANHPI Diabetes Coalition, and manager of its “Screen at 23” campaign. He also coordinates the Minority Physicians’ Alliance, a coalition of physician organizations that represent African American, Hispanic, Native American, and AANHPI serving providers.
David is a writer who has worked in public health since 2009, where he is passionate about breaking down high level health messages and policy talk so they can be better understood. He specializes in health communications and program development with a focus on Asian American, Native Hawaiian, and Pacific Islander (AANHPI) health disparities.
In the past he has interned with the National Institute on Minority Health Disparities as well as China’s National Center for AIDS and HIV Prevention and Control.
STUART FONG M.D. is the current Chair of the San Francisco Hep B Free Bay Area Campaign.
He was one of the original steering committee members, who founded SF Hep B Free. A grass roots organization who developed a public and private partnership to provide community awareness and education; screening efforts and linkage to care around Hepatitis B. One of the greatest Asian American health disparities. Stuart also served as an instructor at San Francisco State University, in the Asian American Department, teaching a course dealing with Asian Health, looking at Asian American health disparities.
Stuart is a third generation Chinese and Korean American, born in San Francisco Chinatown, at Chinese Hospital. His family’s roots in the community provided him with insights to the Chinese American culture, history, and more importantly the health care issues within the community
SANJEEV MEHTA, M.D., M.P.H is a health services researcher who focuses on epidemiological evaluations of diabetes care models and clinical outcomes.
His initial research focused on the impact of nutrition and dietary behaviors on glycemic control in youth with type 1 diabetes. Following several studies, he served as co-investigator of a 5-year, randomized control trial aimed at improving the dietary quality and glycemic control for youth with type 1 diabetes. He has experience in qualitative, quantitative, and mixed methods research gained while conducting numerous retrospective analyses, cross-sectional assessments, and prospective studies. While engaged in pediatric type 1 diabetes research, Dr. Mehta began cultivating his interest in the role of health information technology to improve and assess current diabetes care. He has a strong interest in leveraging health information technology (e.g. electronic health records, cloud-based glucose uploads, and diabetes registries) to improve the safety and efficiency of diabetes care at Joslin and across the country. He serves on multiple, national collaboratives focused on clinical research and quality improvement for children and adults with type 1 or type 2 diabetes. He has received funding from NIH, private foundations, industry, and local grants to support his clinical investigations and quality improvement initiatives. In addition to his clinical research, Dr. Mehta is the Chief Medical Information Officer and Director of Quality at the Joslin Diabetes Center. He has been a staff physician in the Pediatric, Adolescent, and Young Adult Section since 2007.
YILING CHENG, M.D., PH.D. is an epidemiologist with the Division of Diabetes Translation of the Centers for Disease Control. Previously, he was a clinical epidemiologist with the Cooper Institute, a vital statistician with the South Carolina Department of Health and Environmental Control, and a lecturer of epidemiology with the medical college of Soochow University.
He has received his PhD in epidemiology from the University of South Carolina and his MB in medicine (an equivalent degree of MD in the USA) from the Soochow University in China. He has decades of research and teaching experiences related to diabetes & obesity, cardiovascular diseases, disease surveillance, physical activity and lifestyle intervention, infection diseases, statistical methodology, survey design & complex survey data analysis, and health disparity. Through the course of his career he has published more than 80 articles on peer-reviewed journals, 5 articles have been nominated for the CDC Shepard Award. He is also a recipient of the 2017 CDC Honorable Mention of the Statistical Science Award, and a 2018 CDC Honor Award Nominee in Excellence in Program or Policy Evaluation. He has led multiple projects designed to estimate the burden and consequences of diabetes and diabetes related complications.
MARIA ROSARIO (HAPPY) G. ARANETA, PH.D. is Professor of Epidemiology at the Department of Family Medicine and Public Health, University of California San Diego (UCSD).
She is the co-Principal Investigator of the Diabetes Prevention Program (DPP) Outcomes Study at UCSD, and PI of the UCSD Filipino Health Study, a longitudinal clinical study of diabetes, cardiovascular disease, and osteoporosis among Filipino-American men and women. Dr. Araneta received the 2014 American Diabetes Association’s (ADA) Vivian Fonseca Award for her research on diabetes in Asians and Pacific Islanders, the ADA’s “2015 Best of Care” recognition for authoring one of 9 most noteworthy articles in Diabetes Care in 2015, and was the Inaugural Endowed Lecturer for the Lawrence and Evelyn Wing Family Lectureship on Diabetes at Joslin Diabetes Center, Harvard Medical School in 2017. She serves on the National Institutes of Health (NIH) Advisory Council for the National Institute on Minority Health and Health Disparities (NIMHD), and was recently appointed to the NIH Council of Councils.
FRANK HU, M.D. is Chair of Department of Nutrition, Fredrick J. Stare Professor of Nutrition and Epidemiology at Harvard T.H. Chan School of Public Health and Professor of Medicine, Harvard Medical School and Brigham and Women’s Hospital.
He serves as Co-director of the Program in Obesity Epidemiology and Prevention at Harvard and Director of the Boston Nutrition and Obesity Research Center (BNORC) Epidemiology and Genetics Core. Dr. Hu received his MD from Tongji Medical College in China and a PhD in Epidemiology from University of Illinois at Chicago. His research is focused on nutritional and lifestyle epidemiology, prevention of obesity and cardio metabolic diseases, gene-environment interactions, and nutritional metabolomics. In 2010, Dr. Hu received the American Diabetes Association Kelly West Award for Outstanding Achievement in Epidemiology. He has served on the Institute of Medicine (IOM) Committee on Preventing the Global Epidemic of Cardiovascular Disease, the AHA/ACC Obesity Guideline Expert Panel, and the 2015 Dietary Guidelines Advisory Committee, USDA/HHS. He currently serves on the editorial boards of Lancet Diabetes & Endocrinology, Diabetes Care, and Clinical Chemistry. Dr. Hu was elected to the U.S. National Academy of Medicine in 2015.